MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKN1C and overall survival

Genes Chromosomes and Cancer

Volumn 49, Issue 7, 2010, Pages 577-584

  Wurz, Kaitlyn ^a   Garcia, Rochelle L ^a   Goff, Barbara A ^a   Mitchell, Patrick S ^b   Lee, Jun Haeng ^b,c   Tewari, Muneesh ^b   Swisher, Elizabeth M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; MICRORNA; MICRORNA 221; MICRORNA 222; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; EPIGENETICS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; MUTATION; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION;

CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 77953213140     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20768     Document Type: Article

References (24)

1. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H. 2005. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33:2697-2706. (Pubitemid 41511287)
2. Baekelandt M, Holm R, Trope CG, Nesland JM, Kristensen GB. 1999. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study. Clin Cancer Res 5:2848-2853. (Pubitemid 29493962)
3. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233.
5. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. 2009. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4:e5279.
6. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih Ie M, Zhang Y, Wood W, III, Becker KG, Morin PJ. 2008. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3:e2436.
7. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M. 2008. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27:5651-5661.
8. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. 2006. MicroRNA expression and function in cancer. Trends Mol Med 12:580-587.
9. Gillies JK, Lorimer IA. 2007. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6:2005-2009.
10. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699-8707.
11. Khouja MH, Baekelandt M, Nesland JM, Holm R. 2007. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma. Int J Gynecol Pathol 26:418-425. (Pubitemid 47476327)
12. Larson PS, Schlechter BL, King CL, Yang Q, Glass CN, Mack C, Pistey R, de Las Morenas A, Rosenberg CL. 2008. CDKN1C/ p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer 8:68.
13. leSage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafre SA, Farace MG, Agami R. 2007. Regulation of the p27(Kip1) tumor suppressor by miR- 221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708.
14. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M. 2008. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105:13556-13561.
15. Masciullo V, Sgambato A, Pacilio C, Pucci B, Ferrandina G, Palazzo J, Carbone A, Cittadini A, Mancuso S, Scambia G, Giordano A. 1999. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res 59:3790-3794. (Pubitemid 29381888)
16. Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, Croce CM, Stein GS. 2008. MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 68:2773-2780. (Pubitemid 351556275)
17. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK. 2008. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359:2641-2650.
18. Rosenberg E, Demopoulos RI, Zeleniuch-Jacquotte A, Yee H, Sorich J, Speyer JL, Newcomb EW. 2001. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival. Hum Pathol 32:808-813. (Pubitemid 32803981)
19. Sui L, Tokuda M, Ohno M, Hatase O, Hando T. 1999. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors. Gynecol Oncol 73:202-209. (Pubitemid 29215732)
20. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M. 2002. Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors. Anticancer Res 22:3191-3196. (Pubitemid 36070092)
21. Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M. 2009. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 4:e5311.
22. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G. 2006. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103:9136-9141.
23. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Butzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G. 2008. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 105:7004-7009.
24. Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ, Mok SC, Boyd J, Birrer MJ. 2003. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clin Cancer Res 9:4811-4818.